About Dendreon Corporation
Dendreon Pharmaceuticals LLC is a biotechnology company. Its lead product, Provenge, is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells that have been incubated with the Dendreon PAP-GM-CSF fusion protein. Phase III clinical trial results demonstrating a survival benefit for prostate cancer patients receiving the drug were presented at the AUA meeting on April 28, 2009. After going through the approval process, Provenge was given full approval by the FDA on April 29, 2010. Dendreon's stock value fell 66% on August 4, 2011, after abandoning its forecast for its debut drug Provenge.
Source: Wikipedia
HeadquartersCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Founded2013
StatusActive
Patents134 patents
HUMORAL IMMUNE RESPONSE AGAINST TUMOR ANTIGENS AFTER TREATMENT WITH A CANCER ANTIGEN SPECIFIC ACTIVE IMMUNOTHERAPY AND ITS ASSOCIATION WITH…CA2923433C · 2020
Humoral immune response against tumor antigens after treatment with a cancer antigen specific active immunotherapy and its association with…US10261091B2 · 2019
Sign in to see all 134 patents
Browse the full patent portfolio, with publication numbers, dates and families.
Sign in Create an account with your emailIt's free
By continuing, you agree to Heelky's User Agreement, Privacy Policy and Cookie Policy.
Reviews
No reviews yet. Worked with Dendreon Corporation? Be the first to share your experience.
Legal information
| Legal name | Dendreon Corporation |
|---|---|
| LEI | 549300C0XK81HDI8KK82View on GLEIF ↗ |
| Registered address | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Status | Active |
Sources: GLEIF · updated Oct. 16, 2026
Contact & links
Location
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Is this your company?
Claim this page for free to add your logo, products, photos and jobs, and to answer reviews.
Claim this pageJoin Heelky to connect, hire and grow
Create a free account to message people, apply to jobs and post missions.
Join now — it's free